Currently, several studies exploring the potential of HIF-1α inhibition for treating cancer are ongoing, as HIF-1α activity increases solid tumor survival, as well as tumor aggressiveness, invasion, and metastasis [150, 152]. Here, HIF1A is linked to neoplasm.